A
4.66
0.17 (3.67%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 看涨 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 看涨 | |
| 股票 | Aquestive Therapeutics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.7
| 分析师共识 | NA |
| 内部交易活动 | -3.0 |
| 价格波动 | 1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.72 |
|
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 5.62% |
| 机构持股比例 | 48.90% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Bratton Capital Management, L.P. | 30 Jun 2026 | 9,810,958 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BARBER DANIEL | - | 4.29 | -25,000 | -107,250 |
| 累积净数量 | -25,000 | |||
| 累积净值 ($) | -107,250 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 4.29 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BARBER DANIEL | 职员 | 17 Aug 2026 | 卖 (-) | 25,000 | 4.29 | 107,250 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合